Cardiovascular risk screening program in Australian community pharmacies

Pharmacy World and Science

Volumn 32, Issue 3, 2010, Pages 373-380

  Peterson, Gregory M ^a   Fitzmaurice, Kimbra D ^a   Kruup, Helen ^a   Jackson, Shane L ^a   Rasiah, Rohan L ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Australia; Cardiovascular disease; Detection; Pharmacy; Risk; Screening

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; EXERCISE; FAMILY HISTORY; FEMALE; FOLLOW UP; HEALTH EDUCATION; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; MALE; MASS SCREENING; OBESITY; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT REFERRAL; PHARMACY; RISK ASSESSMENT; RISK REDUCTION; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHARMACISTS; RISK FACTORS;

EID: 77953322262     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9379-8     Document Type: Article

References (29)

1. World Health Organization. Neglected global epidemics: three growing threats. The World Health Report-shaping the future. Geneva: World Health Organization; 2003. p. 83-102.
2. Australian Institute of Health and Welfare. Australia's health 2006. AIHW cat. no. AUS 73. Canberra: AIHW. 2006.
3. National Heart Foundation of Australia. The shifting burden of cardiovascular disease. Report prepared by Access Economics 2005. Canberra: National Heart Foundation of Australia.
4. S Yusuf S Hawken S Ounpuu, et al. 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 937 952 10.1016/S0140-6736(04) 17018-9 10.1016/S0140-6736(04)17018-9 15364185 (Pubitemid 39208455)
5. R Taylor A Dobson M Mirzaei 2006 Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades Eur J Cardiovasc Prev Rehabil 13 760 768 10.1097/01.hjr.0000220581. 42387.d4 10.1097/01.hjr.0000220581.42387.d4 17001216 (Pubitemid 44454849)
6. Prepared by: British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society. The Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005;91(Suppl 5):v1-52. doi: 10.1136/hrt.2005.079988. (Pubitemid 43021884)
7. A Tonkin P Barter J Best, et al. 2005 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management-2005 Heart Lung Circ 14 275 291 10.1016/j.hlc.2005.10.009 10.1016/j.hlc.2005.10.009 16361000 (Pubitemid 43055996)
8. AW Joyce VB Sunderland S Burrows, et al. 2007 Community pharmacy's role in promotion of healthy behaviours J Pharm Pract Res 37 42 44
9. S Phillips L Wyndham J Shaw S Walker 1988 How accurately does the Reflotron dry-chemistry system measure plasma total cholesterol levels when used as a community-screening device? Med J Aust 149 122 125 1:STN:280: DyaL1c3ovVWjsQ%3D%3D 3398798
10. S Kinlay 1988 Comparison of Reflotron and laboratory cholesterol measurements Med J Aust 149 126 129 1:STN:280:DyaL1c3ovVWjtg%3D%3D 3398799
11. MJ Ball IK Robertson M Woods 1994 Reflotron cholesterol measurement in general practice-accuracy and detection of errors Ann Clin Biochem 31 556 560 1:CAS:528:DyaK2MXis1CrtbY%3D 7880074
12. LC Gregory SH Duh RH Christenson 1994 Eight compact analysis systems evaluated for measuring total cholesterol Clin Chem 40 579 585 1:CAS:528:DyaK2cXis1Ghtb0%3D 8149614
13. JR Pearson LJ Dusenbury R Bakes-Martin M Loverde J Johnson RL Byyny 1988 Evaluation of a simple method for measuring blood cholesterol levels using non-laboratory observers Am J Med 85 369 374 10.1016/0002-9343(88)90589-X 10.1016/0002-9343(88)90589-X 1:STN:280:DyaL1czisVGjtA%3D%3D 3414733
14. G Thue S Sandberg DG Bullock 1993 Comparison of the use of a dry chemistry analyser in primary care in Norway and the United Kingdom Br J Gen Pract 43 10 14 1:STN:280:DyaK3s3gslOqsQ%3D%3D 8457356
15. GR Warnick GJ Boerma G Assmann, et al. 1993 Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens Clin Chem 39 271 277 1:CAS:528: DyaK3sXhsVaksrY%3D 8432016
16. New Zealand Guidelines Group. The assessment and management of cardiovascular risk, 2003. Available at: http://www.nzgg.org.nz. Accessed June 2007.
17. British Cardiac Society 2000 Joint British recommendations on prevention of coronary heart disease in clinical practice: summary BMJ 320 705 708 10.1136/bmj.320.7236.705 10.1136/bmj.320.7236.705
18. R Teh T Chen I Krass 2001 Consumer perspectives of pharmacist delivered health information and screening services Int J Pharm Pract 9 261 267
19. JS Humphreys F Rolley HC Weinand 1993 Evaluating the importance of information sources for preventive health care in rural Australia Aust J Public Health 17 149 157 1:STN:280:DyaK2c%2Fgt1Gqsg%3D%3D 8399709
20. Australian Government. Diabetes Pilot Program Questions and Answers. http://www.health.gov.au/internet/wcms/publishing.nsf/content/ppsac-qa-dpp. Accessed June 2007.
21. AE Korten PA Jacomb Z Jiao H Christensen, et al. 1998 Predictors of GP service use: a community survey of an elderly Australian sample Aust N Z J Public Health 22 609 615 10.1111/j.1467-842X.1998.tb01447.x 10.1111/j.1467-842X. 1998.tb01447.x 1:STN:280:DyaK1cvhs1yrsw%3D%3D 9744218
22. R Parslow A Jorm H Christensen, et al. 2004 Gender differences in factors affecting use of health services: an analysis of a community study of middle-aged and older Australians Soc Sci Med 59 2121 2129 10.1016/j.socscimed. 2004.03.018 10.1016/j.socscimed.2004.03.018 15351477 (Pubitemid 39200634)
23. RT Tsuyuki JA Johnson KK Teo, et al. 2002 A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP) Arch Intern Med 162 1149 1155 10.1001/archinte.162.10.1149 10.1001/archinte.162.10.1149 12020186
24. I Chabot J Moisan JP Gregoire A Milot 2003 Pharmacist intervention program for control of hypertension Ann Pharmacother 37 1186 1193 10.1345/aph.1C267 10.1345/aph.1C267 12921497 (Pubitemid 37040206)
25. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2004;CD003698.
26. JK Lee KA Grace AJ Taylor 2006 Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial JAMA 296 2563 2571 10.1001/jama.296.21.joc60162 10.1001/jama.296.21.joc60162 1:CAS:528: DC%2BD28Xht12lsbnL 17101639 (Pubitemid 44903860)
27. I Krass CL Armour B Mitchell, et al. 2007 The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia Diabet Med 24 677 683 10.1111/j.1464-5491.2007.02143.x 10.1111/j.1464-5491.2007. 02143.x 1:CAS:528:DC%2BD2sXot12rsrc%3D 17523968 (Pubitemid 46808869)
28. SA Mangum KR Kraenow WA Narducci 2003 Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects J Am Pharm Assoc 43 1 50 55 10.1331/10865800360467042 10.1331/10865800360467042
29. Snella KA, Canales AE, Irons BK, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006 May-Jun;46(3):370-7. doi: 10.1331/154434506777069598.